Our Research Priorities
Drive Strategic Investments
April 16, 2014
Some new projects in the MJFF-funded portfolio focus on learning more about the protein parkin and targeting it with therapies to slow or stop Parkinson's.
April 14, 2014
Researchers have reported on a potential route through which mutations in the LRRK2 gene — the greatest known genetic contributor to Parkinson's disease (PD) — lead to cell death.
UPCOMING FUNDING PROGRAM DEADLINES
Deadline: Pre-Proposals Due: March 11, 2014
Three-year grants to promote understanding of the protein LRRK2 and development of LRRK2-based therapeutics.†
Deadline: Letters of Intent Due: March 19, 2014
Two-year grants to stimulate collaborative analyses across the Alzheimerís disease (AD) and Parkinsonís disease (PD) research enterprises.